baber/WOPTO huggingface dataset:
Patent EP-0779991-B1 (EP)
Inventor: BOLGIANO D RIDGELY
IPC: H04W4/90
Filed: 1995-08-31
Granted: 2007-10-10
Abstract: Système de télécommunication sans fil associant la diversité dans le temps et dans l'espace dans le but de réduire l'évanouissement et de simplifier la conception des récepteurs. Plus particulièrement, un paquet de données portant le trafic téléphonique numérique est transmis à trois instants différents à partir de trois antennes différentes (A-C). Par conséquent, le récepteur d'abonné mobile (10) reçoit le même paquet de données à trois instants différents et en provenance de trois antennes différentes, et il utilise le meilleur paquet de données, ou la meilleure combinaison de paquets de données, pour atténuer les effets de l'évanouissement. Une station de transfert (54, 56, 58) reçoit un signal d'accès multiple par multiplexage à répartition dans le temps (AMRT) provenant d'une station de base portant le trafic téléphonique de paquets de données, afin de former trois répartitions de paquets de données au niveau de trois emplacements d'antenne répartis dans l'espace. En outre, la station de transfert module un système d'accès multiple par difference de code (AMDC) à l'aide d'un signal AMRT reliant le récepteur d'abonné mobile à la station de transfert. Chaque paquet de données reçu par la station de transfert est donc retransmis à trois instants différents en direction du poste d'abonné mobile par l'intermédiaire d'une liaison AMDC. Selon un mode de réalisation, chaque station de transfert comprend les trois antennes réparties dans l'espace.
Patent EP-0780649-B1 (EP)
Inventor: SCHEFFER KAREL DIRK
IPC: F25J3/06
Filed: 1996-12-16
Granted: 2001-07-04
Abstract: The invention relates to a method for the removal of nitrogen from natural gas by means of cryocondensation. According to the invention liquid oxygen is used as the cooling means. Usually the natural gas has a nitrogen content of about 14% by volume. The invention further relates to an installation for the removal of nitrogen from natural gas. <IMAGE>
Patent EP-0766214-B1 (EP)
Inventor: DISCORS MICHEL
IPC: G08B13/24
Filed: 1996-09-11
Granted: 1998-08-26
Abstract: The protection system has a thin conformal circuit attached to the book to be protected. There is a three section machine (100,200,300) with a front display screen (202) to disable the alarm. The book is placed on the machine operating surface (310), and positioned by a side tab (311). The upper section (201) reads the magnetic strip on the book, and a screening foil is pushed through a lower hole (312) onto the book side. A validation button operates the alarm cancellation process.
Patent EP-0808494-B1 (EP)
Title: Process for the automated dissemination of current operational data from a transport facility
Inventor: BALMER WALTER
IPC: G09B29/10
Filed: 1996-02-07
Granted: 1998-12-16
Abstract: The proposed process for the automated dissemination of current operational data from a transport facility involves real-time transmission of the operational data to an information exchange (7) where they are mixed into a picture (for example). The picture which is thus constantly updated is broadcast as a television signal over a broad-band communication network (14). It is thus possible at any time to obtain information through the television set (15.1,..., 15.4) on the current status of the transport facilities. The system proposed is suitable in particular for use in skiing areas for indicating which transport facilities, pistes, paths, etc., are open or closed.
Patent EP-0831754-B1 (EP)
Inventor: PHAN LOC
IPC: A61F2/00
Filed: 1996-06-04
Granted: 2003-08-20
Abstract: A stent designed to be carried on the balloon of a balloon catheter to a target site is described. The stent is formed of a series of expandable, strip-like segments, each formed of a memory polymer and adapted for movement between a closed, high-curvature condition and an expanded, low-curvature condition upon exposure to a selected stimulus.
Patent EP-0832130-B1 (EP)
Inventor: WERTZ CURTIS E
IPC: A61P7/08
Filed: 1996-06-05
Granted: 2000-04-26
Abstract: A method for producing a stable polymerized hemoglobin blood-substitute from blood. The method of this invention includes contacting a polymerized hemoglobin solution with a hydroxyapatite HPLC column and recovering the substantially pure polymerized hemoglobin.
Patent EP-0842519-B1 (EP)
Inventor: CATTANEO FREDERIC
IPC: H01F41/082
Filed: 1996-07-19
Granted: 1999-09-08
Abstract: For forming a cylindrical coil (3) on a rectilinear arm of a magnetic circuit (1) having a very small air-gap (2), a wire guide member (6) has a wire inlet portion (8), a wire outlet portion (9) and an elongated intermediary portion (11) arranged for effecting a rotary movement about the axis (4) of the coil (3) and a reciprocating movement in the axial direction of the coil (3). The intermediary portion of the wire guide member has, over a length at least equal to that of the coil to be formed, a height smaller than the length of the air-gap so that it can move through the air-gap in the longitudinal and in the transverse directions.
Patent EP-0838071-B1 (EP)
Inventor: FLEURY ANNETTE
IPC: G07F11/68
Filed: 1996-07-15
Granted: 1999-10-13
Abstract: An apparatus for automatically dispensing a sheet material from a supply roll of gift-wrapping paper, comprising means for supporting the roll from which a sheet may be unrolled, sheet feeding means and means for cutting the unrolled sheet. The apparatus further includes means for rewinding the unrolled sheet, said means being arranged to enable each cut sheet to be rolled into an output roll having a selected length.
Patent EP-0801771-B1 (EP)
Inventor: KRALOWETZ JOSEPH D
IPC: H04L29/06
Filed: 1996-09-06
Granted: 2003-08-27
Abstract: A method for efficiently setting up a data transmission session over a communication channel between a local endpoint application and a network endpoint application with a proxy engine in a manner that is transparent to the user. The proxy engine is placed in simultaneous communication sessions with the local endpoint application and the network endpoint application. The proxy engine determines the network control protocols that are supported by both the network endpoint application and the local endpoint application. The proxy engine enables the network control protocols that are supported by both the network endpoint application and the local endpoint application. Optionally, the proxy engine enables data compression techniques that are supported by both the network endpoint application and the proxy engine. After the network control protocols and data compression techniques (if desired) are enabled, the proxy engine transmits data between the local endpoint application and the network endpoint application over the communication channel.
Patent EP-0861120-B1 (EP)
Inventor: HOFF MICHAEL H
IPC: C09K23/00
Filed: 1996-10-11
Granted: 2003-08-20
Abstract: The present invention is directed to an oil-free, water-soluble, liquid, polymer dispersion for use in thickening aqueous mediums, particularly completion and workover fluids used in the oil and gas drilling business. The dispersions of the present invention are comprised of hydroxyethyl cellulose and propylene glycol derivatives, preferably both propylene glycol polyether polyols and an aliphatic propylene glycol ether. Optionally these dispersions include water. Because of their low toxicity, these dispersions are particularly useful for drilling in offshore environments. These compositions rapidly disperse in and viscosify a variety of brines, including sea water and other light brines, with minimum shear and without fisheye formation.
Patent EP-0806277-B1 (EP)
Inventor: ITO SUSUMU
IPC: G01L1/00
Filed: 1996-10-25
Granted: 2002-10-02
Abstract: Cette invention concerne un procédé et un appareil permettant d'effectuer une remise à zéro d'un capteur de pression sur une machine de moulage par injection, machine dans laquelle la charge externe s'exerçant sur le capteur de pression est complètement éliminée sans qu'il soit nécessaire de démonter le mécanisme d'injection de celle-ci. Lorsqu'une vis (7) est actionnée dans une condition de sortie faible, on procède à la détection d'une position limite avant (Qf) et d'une position limite arrière (Qb) afin de déterminer la position intermédiaire (Pm) située entre lesdites positions limites. La vis (7) est ensuite déplacée jusqu'à la position intermédiaire (Pm) de manière à éliminer complètement la réaction de la résine s'exerçant directement sur ladite vis (7). Un mouvement de va et vient, dont l'amplitude décroît progressivement, est appliqué à la vis (7) de manière à générer un battement, plus précisement un jeu égal entre un écrou à billes (9) et une vis à billes (8) dans les directions avant et arrière. Ce système permet d'effectuer une remise à zéro d'une cellule de mesure de charge (10) dans des conditions où la pression s'exerçant sur ladite cellule (10) est complètement éliminée.
Patent EP-0959672-B1 (EP)
Title: Detecteur d'activite
Inventor: ANDERSSON PETER
IPC: A01K11/00
Filed: 1996-12-30
Granted: 2003-03-19
Abstract: L'invention porte sur un système de détection de mouvements (11) se fixant à un animal domestique, fonctionnant en parallèle et indépendamment avec un répondeur (1) et comportant un détecteur de mouvements (14) évaluant l'activité de l'animal par émission d'impulsions à chacun de ses mouvements. Chaque heure est subdivisée en plusieurs intervalles à l'intérieur desquels on détermine si l'activité a dépassé un certain seuil. Si c'est le cas, on fait progresser d'une unité une valeur de comptage qui est ensuite transmise une fois par heure avec la valeur de comptage. La transmission régulière de ces informations offre une bonne sécurité pour ce qui est de la réception du signal d'information, et ces informations peuvent servir à des processus compliqués d'évaluation traités par un processeur (7) ou par un PC supplémentaire (9).
Patent EP-0785706-B1 (EP)
Inventor: RUQUE CHRISTIAN
IPC: H05K7/14
Filed: 1997-01-13
Granted: 2003-08-20
Abstract: The drawer (1) includes the motherboard (3) mounted along the front face (6) of the drawer. The motherboard has a number of connectors (21) to which the supported electronic boards (2) are plugged into the side via protruding pins. A second set of output connectors (5) are mounted on an inner wall (11) at the rear of the drawer. The connectors have a rear section (4) connected to cabling (10) and the front of the connectors plug in at the side to the rear part of the supported board.
Patent EP-0895963-B1 (EP)
Inventor: CAMBRIA FLAVIO
IPC: C01B17/34
Filed: 1997-08-05
Granted: 2001-09-19
Abstract: Process for the preparation of anhydrous alcoholic solutions of sodium polysulphides, comprising the stages of:   a) preparing an anhydrous alcoholic solution of sodium sulphide by adding a predetermined amount of an anhydrous crude sodium sulphide with a known titer of Na2S, (preferably sodium sulphide "black ash" obtained from the reduction of sodium sulphate with carbon), to a preestablished volume of an anhydrous alcoholic solvent; b) adding a stoichiometric amount of sulphur to the said anhydrous alcoholic solution, c) reacting the said anhydrous crude sodium sulphide with the sulphur, thus obtaining an anhydrous alcoholic solution of sodium polysulphides.
Patent EP-0889901-B1 (EP)
Title: Procede et intermediaires pour la synthese d'antagonistes de la lh-rh
Inventor: FUNK KENNETH W
IPC: A61K38/00
Filed: 1997-02-06
Granted: 2001-09-19
Abstract: L'invention concerne un procédé permettant de préparer des dérivés décapeptidiques et undecapeptidiques de l'hormone de libération de l'hormone lutéinisante (LH-RH) par la chimie des peptides en phase de solution, ainsi que des peptides intermédiaires utiles pour le même procédé.
Patent EP-0888097-B1 (EP)
Inventor: THALGOTT JOHN S
IPC: A61F2/28
Filed: 1997-03-05
Granted: 2003-12-17
Abstract: La présente invention concerne un implant (10) constituant un disque spinal prothétique comprenant une première paire de côtés opposés (16) sensiblement parallèles et séparés d'une deuxième paire de côtés opposés (18) définissant un espace intérieur (14). Le premier côté de la deuxième paire de côtés présente une courbe sensiblement elliptique rejoignant une première extrémité de la première paire de côtés. Le second côté de la deuxième paire de côtés opposés rejoint d'une manière sensiblement linéaire une deuxième extrémité de la première paire de côtés. Les bords supérieurs et inférieurs de l'implant possèdent un ensemble de crampons (20) se prolongeant jusqu'à reposer sur les vertèbres adjacentes. L'implant est fabriqué dans un métal biocompatible tel que le titane ou un alliage de celui-ci. Le premier et le deuxième côté vont en se rétrécissant depuis la deuxième extrémité jusqu'à la première extrémité. L'espace intérieur possède un bloc d'hydroxyapatite poreuse conçu de manière remplir ledit espace intérieur. L'hydroxyapatite poreuse aide la prothèse à s'intégrer dans la structure vertébrale en permettant qu'elle se développe à travers les pores.
Patent EP-0912194-B1 (EP)
Title: Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
Inventor: AUDONNET JEAN-CHRISTOPHE
IPC: A61P31/14
Filed: 1997-07-16
Granted: 2003-11-05
Abstract: La formule de vaccin bovin contre la pathologie respiratoire des bovins, comprend au moins trois valences de vaccin polynucléotidique comprenant chacune un plasmide intégrant, de manière à l'exprimer in vivo dans les cellules hôtes, un gène d'une valence de pathogène respiratoire bovin, ces valences étant choisies parmi le groupe consistant en virus herpès bovin, virus respiratoire syncitial bovin, virus de la maladie des muqueuses et virus parainfluenza de type 3, les plasmides comprenant, pour chaque valence, un ou plusieurs des gènes choisis parmi le groupe consistant en gB et gD pour le virus herpès bovin, F et G pour le virus respiratoire syncitial bovin, E2, C + E1 + E2 et E1 + E2 pour le virus de la maladie des muqueuses, HN et F pour le virus parainfluenza de type 3.
Patent EP-0951553-B1 (EP)
Inventor: BRANTON PHILIP E
IPC: A61K45/00
Filed: 1997-07-03
Granted: 2003-10-29
Abstract: The present invention relates to a pharmaceutical agent for induction of apoptosis for the treatment of human diseases which involve inappropriate cell survival, which includes adenovirus E4orf4, an analog or a biologically active fragment thereof and/or adenovirus E4orf6, an analog or a biologically active fragment thereof. There is also provided a pharmaceutical composition for the treatment of human diseases which involve inappropriate cell survival, which comprises a therapeutic amount of adenovirus E4orf4, an analog or a biologically active fragment thereof and/or adenovirus E4orf6, an analog or a biologically active fragment thereof in association with a pharmaceutical carrier. Included in the invention are methods for identifying compounds as analogs of the adenovirus E4 death proteins.
Patent EP-0960116-B1 (EP)
Inventor: YEE JIING-KUAN
IPC: C12N15/867
Filed: 1997-07-29
Granted: 2004-06-09
Abstract: The present invention features compositions and methods for the inducible expression of a polypeptide, especially a polypeptide normally cytotoxic to the eukaryotic host cell in which it is to be expressed. A nucleotide sequence encoding a polypeptide of interest is operably linked to an inducible promoter. Expression from the inducible promoter is regulated by a multi-chimeric transactivating factor, composed of a first ligand-binding domain that negatively regulates transcription, a transcriptional activation domain, and a second ligand-binding domain that positively regulates the transcriptional activation function of the transactivator. Transcription of the nucleotide sequence under control of the inducible promoter is activated by the multi-chimeric transactivator when both the ligand that binds the first ligand-binding domain is absent and the ligand that binds the second ligand-binding domain is present. This inducible expression system is particularly useful in the expression of the cytotoxic protein VSV G for the production of pseudotyped retroviral vectors.
Patent EP-0931070-B1 (EP)
Inventor: OTTEN MARTINA
IPC: C07D215/233
Filed: 1997-09-09
Granted: 2003-03-19
Abstract: L'invention concerne des dérivés d'hétaroyle de formule (I) dans laquelle les variables ont la signification suivante: R1, R2 représentent hydrogène, nitro, halogène, cyano, rhodano, hydroxy, mercapto, alkyle C¿1?-C6, alcoxy C1-C6, alkylthio C1-C6, alkylsulfinyle C1-C6, alkylsulfonyle C1-C6, alcoxysulfonyle C1-C6, les 6 derniers restes cités pouvant être éventuellement substitués et/ou fonctionnalisés, phényle, phénoxy, phénylthio, phénylsulfinyle ou phénylsulfonyle, les 5 derniers restes cités pouvant être éventuellement substitués; Z désigne une chaîne tétragonale insaturée, partiellement ou totalement saturée et éventuellement substituée, constituée de trois atomes de carbone et d'un atome d'azote; Q désigne une cyclohexan-1,3-dione liée en position 2, éventuellement substituée. L'invention concerne également les sels à usage agricole de ces dérivés, leur procédé de préparation, des agents les contenant, ainsi que l'utilisation de ces dérivés ou de ces agents pour lutter contre les végétaux indésirables.
Patent EP-0942983-B1 (EP)
Inventor: KUNSCH CHARLES A
IPC: C12N15/09
Filed: 1997-10-30
Granted: 2006-12-20
Abstract: The present invention relates to novel vaccines for the prevention or attenuation of infection by  Streptococcus pneumoniae.  The invention further relates to isolated nucleic acid molecules encoding antigenic polypeptides of  Streptococcus pneumoniae.  Antigenic polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention additionally relates to diagnostic methods for detecting  Streptococcus  nucleic acids, polypeptides and antibodies in a biological sample.
Patent EP-0963564-B1 (EP)
Inventor: NATH GUNTHER
IPC: C08J7/043
Filed: 1997-11-12
Granted: 2002-11-27
Abstract: The present invention provides a lightguide having a liquid core and a tubular cladding made from a plastic material, characterized in that the inner surface of the tubular cladding is coated with a layer containing the copolymer consisting of the components TFE and HFP, or TFE and PMVE wherein the weight proportion of the HFP or the perfluoroalkyl vinyl component in the copolymer may vary between 25% and 50%.
Patent EP-0870605-B1 (EP)
Inventor: STROEHLEIN KARL-HEINZ
IPC: D21H19/84
Filed: 1998-04-07
Granted: 2006-05-31
Abstract: A composite film (I) comprises a support layer of Pergamin (R.T.M.) parchment paper having a barrier layer on one side and a printed image on the other side.
Patent EP-0890329-B1 (EP)
Inventor: STIRNBERG STEFAN
IPC: B65G1/08
Filed: 1998-06-05
Granted: 2004-03-24
Abstract: The unit incorporates a discharge appliance formed by a plunger (10) which lifts the products out of the sloping shaft and lets them slide into a collector-container (13). The plunger has a forward thrust arrangement. A carriage (4) travels along a horizontal runner rail (3) with or without a vertical runner rail (5) with toothed belt drive. Reinforcement struts are between the carriage and vertical rail.
Patent EP-0864414-B1 (EP)
Inventor: PAGNONI GIORGIO
IPC: B30B15/34
Filed: 1998-02-20
Granted: 2003-01-02
Abstract: A press for panels comprising two facing press heads (11, 12) movable towards each other and having heated faced surfaces covered with a finish sheet (24, 25) to press a panel between them. Each press head is formed of a first rear plate (16, 17) and a second front plate (18, 19). The front plate is heated and carries the finish sheet. A layer of elastic material (22, 23) is present between the front and rear plates. <IMAGE>
Patent EP-1027454-B1 (EP)
Inventor: SCHMIDT GUENTER
IPC: C12Q1/37
Filed: 1998-01-23
Granted: 2003-08-13
Abstract: PCT No. PCT/GB98/00201 Sec. 371 Date Sep. 10, 1999 Sec. 102(e) Date Sep. 10, 1999 PCT Filed Jan. 23, 1998 PCT Pub. No. WO98/32876 PCT Pub. Date Jul. 30, 1998A method for characterizing polypeptides, which comprises: (a) treating a sample comprising a population of one or more polypeptides with a cleavage agent which is known to recognize a specific amino acid residue or sequence in polypeptide chains and to cleave at a cleavage site, whereby the population is cleaved to generate peptide fragments; (b) isolating a population of the peptide fragments which bear at one end a reference terminus comprising either only a C-terminus or only an N-terminus and which bear at the other end the cleavage site proximal to the reference terminus; and c) determining a signature sequence of at least some of the isolated fragments, which signature sequence is the sequence of a predetermined number of amino acid residues running from the cleavage site; wherein the signature sequence and the relative position of the cleavage site to the reference terminus characterize the polypeptide or each polypeptide.
Patent EP-0961829-B1 (EP)
Inventor: O'HARE PETER FRANCIS JOSEPH
IPC: A61P37/04
Filed: 1998-01-23
Granted: 2006-03-29
Abstract: Coupled polypeptides and fusion polypeptides for intracellular transport, and their preparation and use, include (i) an aminoacid sequence with the transport function of herpesviral VP22 protein (or a homologue, e.g. from VZV, BHV or MDV) and (ii) another protein sequence selected from (a) proteins for cell cycle control; (b) suicide proteins; (c) antigenic sequences or antigenic proteins from microbial and viral antigens and tumour antigens; (d) immunomodulating proteins; and (e) therapeutic proteins. The coupled proteins can be used for intracellular delivery of protein sequences (ii), to exert the corresponding effector function in the target cell, and the fusion polypeptides can be expressed from corresponding polynucleotides, vectors and host cells.
Patent EP-1000161-B1 (EP)
Inventor: RIESBECK KRISTIAN
IPC: H04W4/00
Filed: 1998-03-26
Granted: 2006-02-22
Abstract: The invention relates to the inhibition of blood coagulation, especially during organ rejection, and in particular the inhibition of delayed vascular rejection.  The invention provides anticoagulant proteins which are anchored to cell membranes. The anticoagulant function is preferably provided by heparin, antithrombin, hirudin, TFPI, tick anticoagulant peptide, or a snake venom factor.  These anticoagulant proteins are preferably prevented from being constitutively expressed at the cell surface. In particular, expression at the cell-surface is regulated according to cell-activation, for instance by targeting the protein to a suitable secretory granule.  Expression of these proteins renders cells, tissues and organs less vulnerable to rejection after transplantation (eg. after xenotransplantation).
Patent EP-1017668-B1 (EP)
Inventor: BOHLANDER RALF
IPC: A01N37/20
Filed: 1998-09-10
Granted: 2003-03-19
Abstract: A process for producing glucoprotamines by condensation of N-substituted propylene diamines with 2-aminoglutaric compounds in which the reaction is carried out in the presence of aminosilicones is disclosed. Glucoprotamines produced in accordance with the disclosed process exhibit improved color quality and longer storage stability.
Patent EP-1025710-B1 (EP)
Inventor: KONDO TETSUJIRO
IPC: H04N19/895
Filed: 1998-10-22
Granted: 2007-08-08
Abstract: A method and system are described for a multiple level shuffling process of a signal that provides for robust error recovery. A signal is defined as multiple levels wherein each level comprises a frame, a plurality of pixels, and a plurality of bits. In one embodiment, shuffling occurs on each level and between levels. Multiple level shuffling causes burst error loss to be distributed across multiple levels thereby facilitating image reconstruction of those areas of the image in which the loss occurred.